The PmirGLO Dual-Luciferase MicroRNA Target Expression Vector is a plasmid-based tool used for studying microRNA (miRNA) target interactions. It contains separate reporter genes for firefly and Renilla luciferases, allowing for the simultaneous measurement of miRNA target activity and normalization.
The 3′ UTR of MECP2 with the hsa-miR-1275 binding region was cloned and inserted into the pmirGLO Dual-Luciferase MicroRNA Target Expression Vector (Promega, USA). The mutant construct with deletion of the binding region of hsa-miR-1275 was an NTC. Primers used for PCR are shown in Table 5. 24 h after transfection with 2 μg of these constructions, the U251 cells were then cotransfected with hsa-miR-1275 mimics, inhibitor, and mimic NTCs. Cells were analyzed for luciferase activity after 48 h by the Luciferase Reporter Assay Kit (Promega, USA), and each construct was compared to that of the pmirGLO vector no-insert control. For each transfection, luciferase activity was averaged from three replicates.
hsa-miR-1275 Gene Ontology
Gene GO
Number of Genes
Percentage
p Value (%)
Fold Enrichment
GO: 0019226 ∼ nerve impulse conduction
43
8.29
0
3.90
GO: 0007268 ∼ synaptic transmission
35
6.74
0
3.73
GO: 0007267 ∼ intercellular signal
52
10.02
0
2.75
GO: 0016337 ∼ intercellular adhesion
28
5.39
0
3.22
GO: 0021700 ∼ maturation
16
3.08
0
5.03
GO: 0030182 ∼ neuronal differentiation
35
6.74
0
2.54
Zhao Y., Lu C., Wang H., Lin Q., Cai L., Meng F., Tesfaye E.B., Lai H.C, & Tzeng C.M. (2020). Identification of hsa-miR-1275 as a Novel Biomarker Targeting MECP2 for Human Epilepsy of Unknown Etiology. Molecular Therapy. Methods & Clinical Development, 19, 398-410.
The PP-1β sequences containing 127–133 bp were amplified and cloned in the pmirGLO dual-luciferase microRNA target expression vector (Promega, E1330, USA). The mutant PP-1β 3′UTR pmirGLO vector was generated using QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene, 200,522, USA) according to the manufacturer’s protocol. Next, 293 T cells were co-transfected with miR-100-5p mimic and either the PP-1β 3′UTR pmirGLO vector or the mutant PP-1β 3′UTR pmirGLO vector. Then, the luciferase activity of the cells was analyzed using a Dual-Glo Luciferase Assay System (Promega, E2920, USA). The relative luciferase activity was determined based on the ratio of firefly/Renilla luminescence.
Li H., Wang L., Ma T., Liu Z, & Gao L. (2023). Exosomes secreted by endothelial cells derived from human induced pluripotent stem cells improve recovery from myocardial infarction in mice. Stem Cell Research & Therapy, 14, 278.
Luciferase reporter assay was used to validate the targeting relationships between miR-193a-5p and CASC9 or 3ʹ-UTR of ERBB2. The wild type (WT) CASC9 sequence or the WT 3ʹ-UTR fragment from ERBB2 mRNA including the predicted binding site of miR-193a-5p were amplified and inserted into the pmirGLO dual-luciferase microRNA target expression vector (Promega, Madison, WI, USA) to construct the report vector pmirGLO-CASC9-WT or pmirGLO-ERBB2-WT. The presumed binding sites of miR-193a-5p in CASC9 or ERBB2 3ʹ-UTR were mutated by GeneArt Site-Directed Mutagenesis PLUS System (cat. No. A14604; Thermo Fisher Science, Inc.). Mutant (MUT) CASC9 sequence or ERBB2 3′-UTR sequence were inserted into the pmirGLO vector to construct report vector pmirGLO-CASC9-MUT or pmirGLO-ERBB2-MUT. The corresponding reporter vectors and miR-193a-5p or NC mimics were co-transfected into SW480 and HCT116 cells and incubated for 48 hrs. Luciferase activity was then measured via Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA).
Ding Y., Li X., Zhang Y, & Zhang J. (2020). Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer. Cancer Management and Research, 12, 1281-1292.
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required